Zoetis, formerly Pfizer Animal Health, has launched Flexi4, a nutritional supplement for horses containing a patented combination of natural plant extracts designed to help maintain joint flexibility and the management of joint pain.
Flexi4 contains a blend of four plant extracts, Curcumin, Yucca schidigera, Salix alba and Boswellia serrata, which the company says have been shown to have anti-inflammatory, anti-pyretic and analgesic properties as follows:
Mary King, Olympic three day eventing team silver medallist, said: "When performing at the highest level it's important that my horses' joints remain flexible and free of pain. Using Flexi4 has made them more resilient to aches and pains during intense training and I am confident when competing that my horses are feeling the benefit of this natural product, helping them to perform at their very best."
Flexi4 is an apple-flavoured gel that is fed as a once daily supplement. It doesn't contain any substances listed as prohibited by the FEI.* For more information, contact your Zoetis Account Manager, call 0845 300 8034 or email customersupportuk@zoetis.com.
References
*FEI prohibited substance list, 2013
The NHS doctor, television presenter, author and columnist will be sharing his insights on the mental health challenges of working within a caring profession under the constraints of the pandemic.
Dr Ranj is the second keynote speaker to be confirmed, the first being Jenny Campbell and the third to be revealed next month. They will be joining a line-up of more than 100 UK and International contributors during the three days of the event.
Dr Ranj is familiar with the intense pressure that many veterinary professionals are facing when juggling working in a sometimes emotionally stressful environment with that of home life. When the pandemic started Dr Ranj took a step back from media work to focus on supporting the NHS in his role as a paediatric emergency medicine specialist. He said: "Maintaining wellbeing is all about doing the basics right.
“We are in a pandemic and people are under intense pressure - from work, from home life, from a health perspective and so much more. So, despite everything going on around you, make sure you have a routine every day.
"Get out and about safely. Build some physical activity into your schedule. Nourish your body with everything it needs, and make sure you allow yourself some treats too! Take a moment for yourself every day to do something that makes you feel good.
"Take time to connect with others safely and check in on the vulnerable too. Celebrate the little victories and achievements that you have. And at the end of the day, make sure you look after your sleep because that's when your brain and body recover from the stresses of everyday. Everything else we do is a bonus on top of those basics. And if you are struggling, make sure you reach out for help and speak to someone."
BSAVA President Ian Ramsey said: "We are delighted to welcome Dr Ranj as one of our three keynote speakers this year. One of the many advantages of Congress evolving into a virtual event for 2021 is that we can be more flexible and creative with our sessions and how we fulfil the needs and expectations of every member of the practice, from clinical, interactive, wellbeing and social perspectives. Our three keynote presentations are eagerly anticipated.”
Prices for BSAVA Virtual Congress start at £99 +VAT for members. To register visit https://www.bsavaevents.com/bsavacongress2021/en/page/home
The Disciplinary Committee (DC) of the Royal College of Veterinary Surgeons last week issued a reprimand to a veterinary surgeon for reckless certification of an equine passport, having found her to have been "wholly indifferent" as to whether the horse had been vaccinated properly against equine influenza.
Eleri Wyn Jones graduated from the University of Liverpool and qualified as a veterinary surgeon in 2006, before joining The Veterinary Practice on Bala Road in Dolgellau, Gwynedd, where she was also an authorised Local Veterinary Inspector (LVI). The principal of that practice is Iwan Parry, who himself was the subject of a DC hearing involving false certification earlier this year, for which he received a one-month suspension from the Register.
The Committee heard how, in late 2007, as Ms Jones was leaving the practice to begin her rounds, she was asked by a non-veterinary colleague to certify in a horse passport that two vaccinations for equine influenza had been administered. The horse in question was being liveried by a regular client of the practice, to whom the practice regularly dispensed veterinary vaccines (although Ms Jones was unaware of this), but had been recently purchased by someone who was not a registered client.
In evidence, Ms Jones admitted the certification process took her only 30 seconds and that she did not obtain any further information about the certification, either from clinical or non-clinical colleagues; nor did she check any other documentation before signing the passport, but assumed the vaccinations had been administered by a veterinary colleague. The Committee had to decide whether Ms Jones had acted recklessly, and to do so, Ms Jones' Counsel suggested the Committee would need to be satisfied that she "did not care less" whether or not the vaccinations had been given by a veterinary surgeon before signing the passport.
In reaching its decision, the Committee took into account the fact Ms Jones, on her own evidence, was generally familiar with RCVS guidance on certification and, as an authorised Local Veterinary Inspector, had certification training. It stated: "Whilst we recognise that Ms Jones received little or no mentoring from Mr Parry, we are satisfied that she would have been aware of the importance of veterinary certification. She was also aware that Mr Parry had been suspended as an LVI, due to certification issues, which had affected her own authorisation."
In view of these facts, and that Ms Jones made no attempt to obtain verification from any other source despite knowing she had not performed the vaccinations herself, the Committee decided that Ms Jones had been "wholly indifferent" to proper vaccination procedures and was therefore guilty of disgraceful professional conduct for reckless certification.
In reaching its decision on sanction, the Committee wished to remind members that cases involving improper certification would ordinarily result in suspension or removal from the Register. "We strongly disapprove of the circumstances in which Ms Jones certified this horse.
Clients, and external bodies, are entitled to rely upon the integrity of the veterinary surgeon in not certifying that horses have been vaccinated unless they have carried out the vaccinations themselves or have obtained full and proper evidence that vaccination has been carried out by another veterinary surgeon," it said.
In mitigation, however, the Committee took into account Ms Jones' age and inexperience, her previously good record, her good character and the significant number of supporting references from colleagues and clients alike. It was also mindful that any sanction's main purpose was to protect animal welfare and maintain public confidence in the profession, rather than to punish.
Nigel Swayne, chairing the Committee, concluded: "This is not a case where undertakings for training or monitoring are required. This isolated incident was a fateful misjudgement on a single occasion. We consider that the sanction most proportionate to the nature and extent of the charge, the public interest and the interests of Ms Jones is a reprimand."
BSAVA Congress was invaded by Orangemen this year to promote the Vet Charity Challenge (VCC) taking place on 15th September 2012.
Veterinary surgeons and industry colleagues are being encouraged to take part in the one day event in which teams of four will complete a series of physical tasks and puzzle-solving challenges. Teams can choose their own routes which include walking / running, cycling and kayaking stages and can make it as easy or hard as they like.
The Vet Charity Challenge is hoping to raise in excess of £20,000 for Hounds for Heroes; SPANA, and Pet Blood Bank. VCC says it will be a great PR opportunity for practices and an opportunity for team-building.
The event will take place at the Royal Agricultural College, Cirencester and all details may be found on www.vetcharitychallenge.co.uk or by phoning 01727 859259. The VCC will provide training guidelines and sponsorship forms. Places are limited so early booking is advisable. To be sure of a place, practices and business are urged to book their team of four by the deadline of Friday 29th June 2012.
The Vet Charity Challenge is sponsored by BCF Technology, Kruuse UK Ltd and Vets2.net and is supported by the VPMA, Mojo Consultancy and JCA Media Group.
The company says the challenge has been developed on the basis of recent research which found that despite 74% of vet-visiting pet owners believing in the value of preventative healthcare, more than half of active pet owners currently don’t see the vet as their primary source of information regarding pet health. Furthermore, those pet owners that fail to return for an annual preventative health consultation often cited their pet being healthy as the main reason.
The new scheme focuses on driving client compliance and footfall by developing the partnership between the vet and pet owner. MSD says it takes a more holistic approach to the relationship, focusing on the vet practice as the primary source of advice and information on all aspects of pet healthcare and wellbeing, whether the pet is healthy or sick.
Practices that register with their MSD Animal Health account manager will receive a toolkit to support their whole team in positioning the practice as a centre for expertise on preventative healthcare and wellbeing.
Caroline Darouj, Nobivac Brand Manager at MSD Animal Health said: :This Challenge is a step-change in terms of our work with vets and support for the practice-pet owner partnership. We are focusing on encouraging communications that highlight the value of the preventative healthcare visit going beyond the obvious benefits of vaccination and parasite control.
"We have recently heard in the news how by just having a conversation about obesity medical practitioners can be an effective catalyst for positive change with patients. It is our belief that changing the conversation and focusing on preventative health has the potential to create positive outcomes in pet health and wellbeing, as well as owner satisfaction and business outcomes."
MSD says the challenge goes beyond the important and widely recognised aspects of preventative healthcare such as vaccination, worming and ectoparasite control to embrace five principal wellbeing needs around care and companionship, feeding, the pet’s environmental, behavioural and preventative health needs. The toolkit will aim to increase the pet owner’s understanding of the value and benefit of annual preventative healthcare visits and develop the level of client engagement with practice staff.
Practices interested in further details should contact their MSD Animal Health Account Manager or call MSD Animal Health on +44 (0) 1908 685 556.
Goddards, the Greater London-based 46-branch, 3 hospital veterinary group has announced the move of its HQ to a new premises in a former police station in Woodford Green, Essex.
Twenty staff from the practice, including senior managers, the accounts and IT teams and the ProActive Pets Wellness Club, are now based at the new premises.
PC Philip Goddard of Woodford Green said: "After 60 years working within our hospital in Wanstead, our support teams had outgrown the office space available. The move provides a greatly enhanced working environment for them and has also freed up space in the hospital that will be used to improve facilities for staff there, including a new lecture room for our Nursing College and Training Department."
The new address is: Claygate House, Manor Road, Woodford Green, Essex IG8 8BX. Telephone: 020 8506 0703.
The report is the culmination of the work of a joint RCVS and VSC BAME Student Support Working Group, set up to explore key issues in supporting BAME veterinary students during their studies.
The Working Group made a total of 14 recommendations, which included:
Stephanie-Rae Flicker is a recent Royal Veterinary College (RVC) graduate who co-chaired the Working Group alongside Professor Rob Pettitt from the University of Liverpool.
She said: “I hope this encourages and supports our veterinary institutions to actively implement change regarding discrimination faced during studies and placements, nurturing role models and helping affected students develop sense of belonging and community during their studies and beyond.
"Many thanks to all that have contributed to the completion of this Report – we hope the recommendations have a lasting impact, and benefit those both already present and yet to enter our profession."
RCVS/VSC BAME Student Support Working Group Report.
Hill's Pet Nutrition reports that more than 1,500 veterinary surgeons and nurses have already subscribed for its series of feline webinars, hosted by Professor Danielle Gunn Moore. Indeed, the company says the series has been so popular that vets are advised to register for a place to watch the rest of the series, as soon as possible.
The first Webinar's topic, hosted by Professor Gunn Moore, was feline liver disease, a condition that many find difficult to diagnose and treat. Using a case study approach, primary and secondary hepatopathies and conditions such as cholangiohepatitis and triaditis were discussed, as well as useful treatments and nutritional support. If you missed the lecture the first time round, or want to check specific details or doses, watch Professor Gunn Moore's presentation or download her notes at www.thewebinarvet.com/hills-webinars.
Martha Cannon BA VetMB DSAM (fel) MRCVS will present the next webinar in the series, entitled A Practical Approach to Renal Disease on 2nd March.
To register for any of Hill's Feline Webinar Series, free of charge please go to www.thewebinarvet.com/hills and enter code hillsnl
Q Fever is caused by the bacterium Coxiella burnetii, which can infect humans, cattle, goats, sheep and many other mammals, as well as reptiles, ticks and birds.
Known originally as Query fever, it was first identified in Australia in 1935 after an outbreak of disease in abattoir workers.
Ceva says half of UK dairy farms may be at risk of Q Fever1, 2.
The webinar, which will be presented by Jonathan Statham MA VetMB DCHP FRCVS (pictured right), an RCVS-registered specialist in cattle health and co-author of the ‘Dairy Herd Health’ textbook, will count towards 1.5 hours of CPD.
It will cover the UK prevalence of Q Fever in herds, its cause and transmission, together with identification and diagnostics.
It will also look at the variations between livestock species, disease prevention and its risk to humans as a zoonosis.
Jonathan said: "Q Fever is of much higher profile in many other parts of the world such as Australia and has been notifiable for some years with national testing programmes in a number of European countries such as Germany.
“Recently Q Fever has become notifiable in the UK and climate change is changing the future risk profile."
Renzo Di Florio, veterinary advisor at Ceva said: “The disease causes issues with reproduction and fertility and has the potential to have significant impact on livestock health and productivity.
"However, awareness is low amongst the farming industry.
“Our Q Fever webinar will help raise awareness of the disease and the preventative measures that can be put in place to help protect those working with livestock on a regular basis and reduce the impact of Q Fever on farms.
To register for the webinar or if you have further questions, e-mail cevauk-webinars@ceva.com
Under the previous system, complaints made about a veterinary surgeon or veterinary nurse would, at Stage One, be considered by a Case Examiner Group (CEG) which would determine if there was an arguable case of serious professional misconduct.
If the CEG found there was an arguable case, it would then refer it to Stage Two of the process for consideration by the Preliminary Investigation Committee.
The CEG stage of the process has now been replaced by Stage One Preliminary Investigation Committees which, rather than using the ‘arguable case’ threshold, will consider from the outset whether there is a realistic prospect that the alleged conduct constitutes serious professional misconduct and that there is sufficient evidence.
The new Stage One Preliminary Investigation Committees will comprise members of the professions and lay people, and will be assisted in their investigations by an RCVS Case Manager who will also be the first point of contact for those raising concerns, witnesses and respondents in the case.
Eleanor Ferguson, RCVS Registrar and Director of Legal Services, said: “By keeping to one consistent threshold for serious professional misconduct throughout the concerns investigation process, we hope that these changes will help to simplify our investigations while still ensuring that the process remains robust and thorough.
"We also hope that, in time and when the changes are fully bedded in, we may also see a swifter resolution to some cases, as concerns that may previously been referred on to Stage Two of the process can now be closed at Stage One.”
If a Stage One Preliminary Investigation Committee cannot close a case it will refer it on to a Stage Two Preliminary Investigation Committee.
This will gather additional information and evidence and then determine if there is a realistic prospect of finding serious professional misconduct and if it is in the public interest for the case to go to Stage Three - a full, public Disciplinary Committee hearing.
Eleanor added: “The introduction of these new stages is the first step in the programme of reform of our concerns investigation and disciplinary processes.
"Next year we will be looking to introduce our Charter Case Protocol which will be a way of resolving some less serious cases of alleged misconduct where it would not necessarily be in the public interest to hold a full Disciplinary Committee hearing.”
www.rcvs.org.uk/concerns
Cranial cruciate ligament insufficiency (CCLI) affects 3% to 5% of dogs1.
Past research has demonstrated satisfactory short (6-12 weeks)2 and medium (mean 16 months)3 term outcomes for lame dogs treated with TTA.
However, Steve says there is limited research on longer (>16 months) follow-up periods.
It has also been speculated that dogs with tibial plateau angles (TPA) of greater than 30⁰ are not well suited for a TTA4.
For the study5, the researchers reviewed patient records for a total of 149 TTA-Rapid procedures carried out in 120 dogs over an 80 month period.
They also reviewed owner questionnaires that evaluated the outcome of at least six months after surgery, using a validated clinical metrology instrument, Liverpool Osteoarthritis in Dogs (LOAD).
Follow-up questionnaires were received from owners of 64 of the 120 dogs (53.3%), with a median follow-up time of 37.5 months.
This cohort included a wide range of breeds, aged between 2&12 years and with bodyweights ranging from 6.3 to 41.8kg.
The dogs included 37 females and 27 males, and of the 79 limbs treated in these dogs, 41 were left and 38 were right.
The researchers found 26 of the dogs (40.6%) had a TTA performed with a TPA less than 30◦ and 38 (59.4%) with a TPA of 30◦ or more.
Of the 79 procedures, meniscal injury was noted in 27 (34.2%), surgery to stabilise the patella was required in 11 (13.9%), there was one surgical site infection (treated successfully with a short course of antibiotics), one dog sustained a fracture of the tibial seven days after surgery, and one sustained a late meniscal tear 12 months after initial surgery (treated successfully by partial meniscectomy).
The outcome was judged to be satisfactory, based on frequency of lameness, in 63 (98.4%), while satisfactory outcomes were achieved in 61 (95.3%) based on severity of lameness and in 50 (78.1%) based on mobility score.
Statistical analysis showed that age, bodyweight, tibial plateau angle (TPA), meniscal injury, and concurrent patellar surgery did not influence the outcome, but time to follow-up positively correlated with mobility score (suggesting mobility declined with time from surgery).
The researchers concluded that the long-term (median of 37.5 months) outcome for dogs undergoing TTA-Rapid for cranial cruciate ligament disease is satisfactory, with no risk factors associated with poorer outcomes identified.
The study also revealed no evidence to support the suggestion that dogs with TPAs of greater than 30◦ may be inappropriate candidates for TTA - after testing several parameters to judge outcome including frequency of lameness, severity of lameness, distance walked daily and mobility score.
Steve said: “This research is important in trying to ensure that decisions on whether to use this treatment modality, are based on sound clinical evidence.
"The only factor identified that influenced the outcome measure was that of time since surgery.
"All other factors, including TPA, had no effect on the outcome.”
Two recently published studies have demonstrated that the canine anti-emetic Cerenia® (maropitant - Pfizer) which was launched last year also relieves car sickness in dogs.
In a pilot study, 17 dogs were given either Cerenia or placebo one hour before being taken on a car journey. After a washout period of 10-14 days, each dog was crossed over to the other treatment and once again taken on a journey to assess travel sickness. The results showed that likelihood of vomiting was reduced by 70% when the dogs were given Cerenia compared to placebo – but due to the small number of dogs enrolled the results did not reach statistical significance.
The same research group also carried out a large, multicentre, blinded and placebo controlled study of Cerenia in preventing vomiting in 213 dogs known to be prone to travel sickness. They were given a single oral dose of Cerenia or placebo one hour before a car journey. The results showed that Cerenia was associated with a reduction in vomiting of 79% compared to placebo (p<0.0001).
The dosage of Cerenia used in both studies was 8mg/kg dose for the prevention of motion sickness–higher than the 2mg/kg dose that is routinely used to treat general emesis, administered at least one hour before the journey. According to the researchers’ report in the Veterinary Record, the need for a higher dose is linked to the specific neural (central) pathway of emetic stimulation that is involved in motion sickness. Cerenia acts primarily at NK1 receptors in the emetic centre and thus has the ability to block vomiting due to vestibular stimuli.
According to Pfizer, a single oral dose lasts for at least 12 hours, so pets can be dosed the night before an early start. For motion sickness prevention, Cerenia is licensed for up to 2 days’ consecutive use, so owners can use it for a return journey the next day if need be.
Pfizer also says that market research suggests almost one in five dogs suffers from travel sickness, which is not only inconvenient but does also stop some owners from travelling with their pet. In the past, owners have had to rely on OTC (over the counter) remedies or medicines developed for use in humans to prevent travel sickness. Many of these are ineffective or have unwanted effects such as sedation or extrapyramidial effects in dogs. Cerenia is the first anti-emetic to be developed specifically for use in dogs and was launched in April 2007– higher dose tablets aimed specifically for the prevention of travel sickness are expected to be made available early this year.
Virbac is running a special promotion through which UK-based practitioners who order from the company's reproductive product range can claim a free copy of the evidence-based book Clinical Canine and Feline Reproduction by Margaret V. Root Kustritz.
The book covers 100 separate questions across a range of reproductive issues, and currently retails for £47.99.
Virbac product manager Chris Geddes MRCVS said: "We offered this book as part of a promotion in 2010 and it proved extremely popular. As a result we thought we would give vets another chance to get a free copy."
As the Assistant Dean at the Minnesota College of Veterinary Medicine, Margaret V. Root Kustritz is a leading figure in feline and canine reproduction and one of the world's most renowned experts in reproduction. Mr Geddes said: "The book is based on the questions veterinary surgeons have asked her over the years, and so is a valuable reference tool for any vet."
Numbers are limited, and the book is available on on a 'first come first served' basis. Anyone interested should either contact their territory manager or call Virbac on 01359 243243.
The RCVS Charitable Trust has made two 'Blue Sky' grants of £20,000 each for research into feline rotavirus and equine gut bacteria.
One award has been made to Allison German and Kenton Morgan at the University of Liverpool as a Richard Daubney Research Fellowship. This will enable research to be undertaken into the molecular epidemiology and zoonotic potential of feline rotavirus in UK cats.
Allison said: "Feline rotaviruses have been identified in diarrhoeic children in Japan, Italy, Israel and America, but because of limited funding options, there has been no systematic study of rotaviruses in cats, so the prevalence, risk factors and zoonotic potential are unknown. I am pleased that the Trust has recognised the importance of emerging infectious diseases in companion animals and their potential role in animal and human health."
By assessing faecal samples from cats within Cats Protection Adoption Centres in the UK, the study aims to discover the prevalence of rotavirus in this cat population and broadly identify the strains of feline rotavirus that are circulating, including looking for any with identity to human strains. The study will also determine whether the molecular epidemiology of rotavirus in the cat population enables understanding of the diversification and evolution of rotaviruses in people.
A second Blue Sky award of £20,000 has been made to Chris Proudman and Alistair Darby, also at the University of Liverpool, to research the role of gut bacteria in horse health and disease. Called Metagenomic Analytical Utilities for Equines (MANURE), the project will sequence DNA from microbes taken from horse intestines, and analyse the diversity, composition and abundance of the microbial populations. This is expected to improve veterinary understanding of the role of equine gut bacteria, and benefit horses and their owners. Tools being developed to characterise and investigate equine gut microbiota, and findings expected, such as the discovery of novel bacteria, should also be useful to other research.
RCVS Trust Director Cherry Bushell said: "As usual, the standard of applications was very good, although we do continue to receive a relatively high number of applications for projects that the assessors judge to be more 'surveys' than genuine blue sky research.
"In deciding which research to fund, a number of factors are taken into account, such as the quality and strength of the research team, the likelihood of success, and whether a genuine gap in knowledge has been identified. For example, the feline rotavirus research could have important findings in the longer term if it is found that there is genuine risk to human health, and also shows clear potential for further study. Similarly, the equine gut bacteria study is likely to increase considerably knowledge over the longer term and to attract funding from elsewhere for further research."
Supreme Petfoods has announced that Think Rabbit Fortnight, a campaign to help practices engage with rabbit owners, will run from Monday 21st May to Friday 1st June.
Practices can decide how much they wish to participate in the campaign and can opt to receive goodie bags, a 'Think Rabbit' manual detailing how the practice can be more rabbit-friendly, or take the 'Small Furry' Promise.
The event is being backed by RCVS Exotics Specialist, Molly Varga. She said: "I'd encourage all practices to take part in Think Rabbit Fortnight to help improve the health and welfare of the nation's rabbits."
Supreme says that practices which take part in the Think Rabbit Campaign will also have the opportunity to sign up for Level 1 of its 'Better for Bunnies, Better for Business' programme, which it says can double turnover derived from rabbits through an increase in new clients, average visit transaction spend and attendance rates of existing clients.*
Claire Hamblion, Marketing Manager at Supreme says she hopes that it will really encourage practices to focus on how they can develop protocols and routines that will remove barriers to rabbit owners seeking healthcare advice and presenting their pet for treatment.
Binky - voted Britain's Cutest Bunny - will play a starring role in the Think Rabbit campaign to attract the attention of rabbit owners who will also be asked to nominate their rabbit as a VIP (Very Important Pet). Claire said: "Our VIP won't necessarily be the most prettiest, fastest or cleverest bunny but one that has special qualities in the eyes of its owner. I hope vets and nurses will help spread the word and maybe even nominate some very important patients."
To sign up for Think Rabbit Fortnight, visit www.supremepetfoods.com/thinkrabbit, email thinkrabbit@companionconsultancy.com, or telephone 01284 761107.
*Supreme - Better for Bunnies, Better for business programme, Onswitch March 2012
New research from the USA, published in the Equine Veterinary Journal (EVJ), has shown that a toxin from the box elder tree is the likely cause of Seasonal Pasture Myopathy (SPM), the US equivalent of the European disease known as Atypical Myopathy (AM).
According to the British Equine Veterinary Association, preliminary comparisons of these results with cases of AM in Europe suggest that the European condition may be linked to similar trees which could have an important bearing on the future prevention of the disease in Europe.
Seasonal Pasture Myopathy is a highly fatal muscle disease in Midwestern USA and Eastern Canada. A similar disorder called Atypical Myopathy is becoming increasingly frequent in the UK and Northern Europe. Outbreaks of both diseases tend to be seasonal, with most cases occurring in the autumn. Horses that develop SPM and AM are usually kept in sparse pastures with an accumulation of dead leaves dead wood and trees in or around the pasture and are often not fed any supplementary hay or feed.
The research1 identified that seeds from box elder trees were consistently present in the autumn pastures of all 12 horses enrolled in the study. These horses were from 11 different farms and had all presented with the clinical signs of SPM, which include muscular weakness and stiffness, dark urine, periods of recumbency, colic-like signs and muscle trembling. The toxic amino acid hypoglycin A, which is known to cause acquired multiple acyl CoA dehydrogenase deficiency (MADD) was shown to be present in the box elder seeds and hypoglycin metabolites were identified in the serum or urine of all the horses. All but one of the cases proved fatal.
Professor Valberg DVM PhD of the Department of Veterinary Population Medicine, College of Veterinary Medicine, University of Minnesota, who instigated the study, said: "The fact that another acquired form of MADD in rats and humans is caused by hypoglycin A ingestion strengthens our conclusion that hypoglycin A is the likely toxic cause of SPM in horses. We are intending to conduct further studies to determine the factors that affect the highly variable hypoglycin A concentrations in box elder seeds."
Professor Valberg has established collaborative links with groups in Europe in order to investigate if a similar toxin is involved in European Atypical Myopathy. Working with Professor Vince Gerber and Dr Lucia Unger at the University of Bern, Professor Valberg has obtained seeds from a tree related to the Box Elder found on many pastures where Atypical Myopathy has occurred.
Professor Celia Marr, Editor of Equine Veterinary Journal said: "This is a really important step forwards. We don't yet know for sure that the cause of European disease, Atypical Myopathy, is the same as Seasonal Pasture Myopathy in the US. But the clinical signs and MADD aberrations are identical and both conditions have a high fatality rate. It remains to be seen whether this research will help European horses, but there is no doubt that it will allow American horse owners to prevent this devastating condition affecting their horses with immediate effect."
1 Seasonal Pasture Myopathy/Atypical Myopathy in North America associated with Ingestion of Hypoglycin A within Seeds of the Box Elder Tree Stephanie J Valberg DVM PhD1, Beatrice T Sponseller Dr. med. vet2, Adrian D Hegeman PhD3, Jennifer Earing PhD, Jeffery B. Bender DVM MS1, Krishona L Martinson PhD4, Steven E Patterson PhD5, Lawrence Sweetman PhD1
Extensively updated, the new edition reflects the increasing sophistication of reptile medicine and surgery and acknowledges the expanding range of reptile species kept as companion animals.
Part one covers the husbandry aspects of reptile care, including captive maintenance and nutrition, plus a new chapter dedicated to anatomy and physiology.
Part two contains the details necessary to carry out successful clinical examination, anaesthesia, surgery (including endoscopy), treatment (including emergency and critical care), non-invasive imaging, laboratory testing and post-mortem examinations, as well as humane euthanasia.
Part three addresses disease by organ system, covering parasitology and infectious disease.
New to this third edition are also chapters on marine turtle rehabilitation and crocodilians, as well as updates on the handling of venomous reptiles.
Simon Girling said: "This third edition of the BSAVA Manual of Reptiles is another milestone in the commitment of the BSAVA to exotic species medicine. Reptile medicine and surgery is now being accepted as a mainstream discipline within the veterinary world, reflected in the growing number of textbooks and the appearance of postgraduate qualifications."
BSAVA says the new manual will benefit both the general practitioner seeing a small number of reptiles or a more specialist practitioner dealing with these species on a daily basis.
To nominate someone for inclusion in the showcase, visit: https://www.beva.org.uk/60-Faces
BEVA President Lucy Grieve said: "We are proud of BEVA’s heritage and want to recognise our 60th birthday by celebrating some of those who have made a significant difference to the equine veterinary community. We want you to help us identify the 60 individuals who you believe have truly inspired, influenced and progressed the equine veterinary profession for the better.”
Each of the nominated 60 faces will be highlighted on the website and on BEVA’s social media channels. Profile details will include career paths, workplaces and personal contributions to the equine veterinary profession.
Lucy added: "We have already started the list with Colonel John Hickman, Sue Dyson and Peter Rossdale. But there are hundreds of exceptional, deserving individuals who have made a huge difference to the equine veterinary profession and are worthy of our 60 Faces roll call."
The deadline for nominations is Friday 16th April 2021. All nominations are anonymous.
BCF has launched a new operating lease scheme to make it easier for veterinary practices to afford the latest ultrasound and x-ray digital imaging systems.
According to the company, only one scan per week will cover the cost of leasing a system. BCF provides a range of training options to help practices offer imaging services to clients and increase revenue.
Practices pay a fixed monthly payment with no capital outlay. After 3 years they can upgrade to a new system or return the system to BCF. Service and maintenance cover can also be included in the monthly payment to avoid unexpected service or maintenance bills.
For more information call 01506 460023, email info@bcftechnology.com or visit http://www.bcftechnology.com/
The object of the exercise is simply to find out whether a significant number of veterinary professionals feel that they have been bullied, and look at the impact it has had on them.
If a significant number of people say they have, the hope is that the survey will trigger constructive discussion on the subject, both amongst key opinion leaders in the profession and in practice.
One of the biggest challenges in measuring the incidence of bullying in practice is the highly subjective definition of the word. For this reason, the survey asks whether you've been on the receiving end of very specific types of behaviour, ones which most people would agree are at best unconducive to a happy and effective working environment, and at worst, outright bullying.
VetSurgeon.org Editor Arlo Guthrie said: "Early responses to the survey have already shown, if we didn't know it already, that bullying is going on, and how bullies can make life utter hell at work. We just don't yet know the scale of the problem.
"Either way, there are two ways I think this survey could make a difference. Firstly, by discussing the subject openly, so it creates an environment in which bullying behaviour is less likely to happen. Secondly, I suspect that a significant amount of bullying may happen as a consequence of poor communication. For example, if one member of the team thinks another is underperforming but is uncomfortable having a candid but constructive discussion. If there is no other process in place to resolve the issue, they may resort to other types of behaviour which can have a profoundly negative effect on their colleague."
To take part in the survey, please visit: http://www.surveygizmo.com/s3/3783698/Behaviour-In-Practice
The survey was held between the 1st and 5th May and was sent to the 3,139 UK veterinary practices for which the RCVS holds a unique email address. In total it gathered 251 responses (a response rate of 8%) compared to the 532 responses to the initial survey conducted between 3rd and 7th April (a response rate of 17%).
The main changes compared to last month's survey were:
Lizzie Lockett, RCVS CEO, said: "This latest survey has identified some positive trends in terms of a slight uptick in business, including turnover, and fewer incidences of staff having to take time off with COVID or COVID-like symptoms.
“I am glad to see that the framework we published in April has, so far as we can see, provided veterinary professionals with greater guidance and reassurance regarding the fact that if it is feasible to do something safely under social distancing guidelines, then they can go ahead, if they choose to.
"We left plenty of scope for veterinary professionals to use their clinical judgement as to what services actually offer, depending on their facilities, level of staffing, availability of protective equipment, local disease pressures and so on.
"However, it is also clear that we are, by no means, out of the woods and that veterinary businesses are still struggling financially, with some of them reporting a very acute impact of the coronavirus and the associated restrictions on their businesses.
“We will continue to monitor the situation via these regular surveys, with the next one planned for early June. I would urge as many practices as possible to continue to complete them, so that we can build up a stronger evidence-base on how veterinary businesses have been affected. This information is not only vital for our own policy decisions but also allows us to present a stronger case to the Government and other public bodies where we wish to influence the decisions they make that will impact the veterinary professions and businesses.”
The survey results can be read in full at www.rcvs.org.uk/coronavirus-resources.
In his new role, Ian will guide the development of interventions, strategies, process changes and campaigns to improve responsible pharmaceutical usage across Mars Veterinary Health’s 2,500+ global veterinary clinics.
Ian was previously Head of Internal Medicine at Hertfordshire-based Davies Veterinary Specialists and antimicrobial resistance (AMR) subject matter expert on the clinical board of Linnaeus.
Mars says that this new role is one of several actions it is taking to promote pharmaceutical stewardship and combat antimicrobial resistance, include the implementation of a formal responsible pharmaceutical stewardship programme across all its veterinary clinics globally during the next several years.
Ian said: “As one of the leading providers of veterinary care in the world, we have a unique opportunity – and responsibility – to lead the way toward a more sustainable profession.
“Antimicrobial resistance is a critical One Health issue, and I look forward to continue working with colleagues across more than 2,500 clinics to support responsible antibiotic prescribing.
"Energy and interest in this area is growing profession-wide, demonstrating a reassuring recognition of how we can make meaningful improvements for people, pets, and the planet long into the future.”
Janssen Animal Health has made what I am told is a 'very large' donation of Ripercol, a pour-on 20% levamisole w/v broad spectrum anthelminitic for cattle, effective against gastro intestinal nematodes and lungworm, to the Worldwide Veterinary Service (WVS) – a UK registered charity (No.1100485) committed to improving the treatment and welfare of all animal species throughout the world.Nigel Underwood, Livestock Marketing Manager at Janssen said: 'We are very pleased to be able to help improve the health of animals in the developing countries and in turn to help those people who need it most. I’d encourage other pharmaceutical companies and practices to support WVS whenever they can, as they do a fantastic job.'Annie Cook, WVS Director of Veterinary Operations said: 'So far this year we have been able to help over 64 associated charities with nearly £73,000 worth of donated items. This incredibly generous donation of Ripercol from Janssen Animal Health will allow us to provide production animal welfare charities in India, East Africa and South America with a much needed resource'.WVS is currently arranging a Disaster Emergency Response team of veterinary professionals to visit the Internally Displaced People Camps in Kenya created following the election violence. Luke Gamble, WVS Chief Executive Officer, who will be coordinating the team said: 'The high concentration of animals in these camps combined with poor sanitation will promote the spread of disease between animals and is also a public health concern. Simply deworming these animals will improve their productivity and survival, which is vitally important as they are an essential resource to the people in the camps.'
Eurovet Animal Health has launched Thyforon Flavoured (levothyroxine sodium, POM-V), which replaces the company's canine hypothyroid treatment Forthyron.
Eurovet says that Thyforon Flavoured has the same clinical efficacy of Forthyron and veterinary surgeons won't need to make any dose adjustments when transitioning to the new product.
However, Thyforon Flavoured, with its palatable formulation, now offers the benefit of being voluntarily accepted by over 70 per cent of dogs in taste trials1. In addition there is a new 800 mcg formulation which gives more prescribing options, particularly for the treatment of large and giant breeds.Thyforon Flavoured comes as easy-break tablets to make dose adjustment straightforward, in an easy-to-dispense blister pack.
Thyforon Flavoured is available now - the person responsible for placing the practice drug order should just ask for Thyforon Flavoured when placing the next drug order and where appropriate, the practice management system should be updated to reflect the new name.
Reference1. Eurovet Animal Health Internal Study report, acceptance study, November 2011
And the winners are:
Laurent Garosi (The Bourgelat Award for outstanding international contributions to the field of small animal practice), Sarah Girling (The Simon Award for outstanding contributions in the field of veterinary surgery), Kit Sturgess (The Woodrow Award for contributions to the advancement of small animal medicine), Martin Hawes (The Amoroso Award for outstanding contributions to small animal studies), Daniella Dos Santos (The J.A. Wight Memorial Award for an outstanding contribution to the welfare of companion animals) and Claire Bessant (The Ray Butcher Award for an individual who has made a significant contribution to animal welfare in the community).
Other winners included: Marzia Stabile (The Melton Award for the first named author of the best original research article on small animal surgery published in the Journal of Small Animal Practice), Ross Bond (The PetSavers Veterinary Achievement Award for the first author of the most valuable full research paper published following a BSAVA PetSavers' grant) and Rosanne Jepson (The Blaine Award for outstanding contributions to the advancement of small animal veterinary medicine or surgery).
BSAVA Honorary Secretary, Krista Arnold said: “Congratulations to all those that are receiving an accolade.
“All the nominations were exceptional, making judging particularly difficult this year.”